Cargando…

Management of intracranial melanomas in the era of precision medicine

Melanoma is the most lethal of skin cancers, in part because of its proclivity for rapid and distant metastasis. It is also potentially the most neurotropic cancer in terms of probability of CNS metastasis from the primary lesion. Despite surgical resection and radiotherapy, prognosis remains guarde...

Descripción completa

Detalles Bibliográficos
Autores principales:	Young, Grace J., Bi, Wenya Linda, Wu, Winona W., Johanns, Tanner M., Dunn, Gavin P., Dunn, Ian F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687693/ https://www.ncbi.nlm.nih.gov/pubmed/29179523 http://dx.doi.org/10.18632/oncotarget.19223

Ejemplares similares

Meningioma Genomics: Diagnostic, Prognostic, and Therapeutic Applications
por: Bi, Wenya Linda, et al.
Publicado: (2016)

BRAF-MEK inhibitors as steroid-sparing bridge prior to checkpoint blockade therapy in symptomatic intracranial melanoma
por: Khaddour, Karam, et al.
Publicado: (2021)

Immunotherapy in the Precision Medicine Era: Melanoma and Beyond
por: Su, Mack Y., et al.
Publicado: (2016)

39607 Mapping the Draining Lymph Nodes in Central Nervous System Malignancies
por: Coxon, Andrew T., et al.
Publicado: (2021)

Distant intracranial failure in melanoma brain metastases treated with stereotactic radiosurgery in the era of immunotherapy and targeted agents
por: Acharya, Sahaja, et al.
Publicado: (2017)

Surgical strategies for intracranial meningioma in the molecular era
por: Dincer, Alper, et al.
Publicado: (2023)

Genomic profile of human meningioma cell lines
por: Mei, Yu, et al.
Publicado: (2017)

Pseudo-Cerebrospinal Fluid Rhinorrhea Resulting from Aberrant Cross-Innervation of Trigeminal and Facial Nerves following Skull Base Surgery
por: Grannan, Benjamin L., et al.
Publicado: (2015)

Cytokine Profiling in Plasma from Patients with Brain Tumors Versus Healthy Individuals using 2 Different Multiplex Immunoassay Platforms
por: Bender, Diane Elizabeth, et al.
Publicado: (2021)

GATA2 Regulates Constitutive PD-L1 and PD-L2 Expression in Brain Tumors
por: Fu, Yujie, et al.
Publicado: (2020)

The impact of systemic precision medicine and immunotherapy treatments on brain metastases
por: Han, Rowland H., et al.
Publicado: (2019)

Precision Medicine: The new era in medicine
por: Twilt, Marinka
Publicado: (2016)

Successful administration of sequential TVEC and pembrolizumab followed by Temozolomide in immunotherapy refractory intracranial metastatic melanoma with acquired B2M mutation
por: Khaddour, Karam, et al.
Publicado: (2020)

Precision Medicine for Intracranial Atherosclerotic Disease
por: Liebeskind, David S.
Publicado: (2021)

Impact of CD4 T cells on intratumoral CD8 T-cell exhaustion and responsiveness to PD-1 blockade therapy in mouse brain tumors
por: Khan, Saad M, et al.
Publicado: (2022)

Dramatic response to targeted therapy in an aggressive olfactory neuroblastoma: illustrative case
por: Gupta, Saksham, et al.
Publicado: (2022)

Addendum: Successful administration of sequential TVEC and pembrolizumab followed by Temozolomide in immunotherapy refractory intracranial metastatic melanoma with acquired B2M mutation
por: Khaddour, Karam, et al.
Publicado: (2023)

Precision Medicine and Precision Nursing: The Era of Biomarkers and Precision Health
por: Ielapi, Nicola, et al.
Publicado: (2020)

TCR-engineered adoptive cell therapy effectively treats intracranial murine glioblastoma
por: Schaettler, Maximilian O, et al.
Publicado: (2023)

INOSA Guidelines in the era of precision medicine
por: Chakraborty, Ranajit
Publicado: (2015)

Cardiovascular Precision Medicine in the Genomics Era
por: Dainis, Alexandra M., et al.
Publicado: (2018)

Gastric Cancer in the Era of Precision Medicine
por: Liu, Xi, et al.
Publicado: (2017)

Cancer Evolution in Precision Medicine Era
por: Karagiannis, Dimitris, et al.
Publicado: (2022)

Antibiotic stewardship in the era of precision medicine
por: Watkins, Richard R
Publicado: (2022)

The Epigenomics of Pituitary Adenoma
por: Hauser, Blake M., et al.
Publicado: (2019)

Precision medicine in the era of artificial intelligence: implications in chronic disease management
por: Subramanian, Murugan, et al.
Publicado: (2020)

Bilateral occipital metastases: Visual deficits and management considerations
por: Zaki, Mark M., et al.
Publicado: (2020)

Osteoglycin promotes meningioma development through downregulation of NF2 and activation of mTOR signaling
por: Mei, Yu, et al.
Publicado: (2017)

Assessing the value of precision medicine health technologies to detect and manage melanoma
por: Mahumud, Rashidul A, et al.
Publicado: (2022)

Prognostic impact of CDKN2A/B deletion, TERT mutation, and EGFR amplification on histological and molecular IDH-wildtype glioblastoma
por: Ma, Sirui, et al.
Publicado: (2020)

Combining targeted therapeutics in the era of precision medicine
por: Papadatos-Pastos, D, et al.
Publicado: (2015)

Arriving at the Right Diagnosis in an Era of Precision Medicine
por: Pulido, Vina, et al.
Publicado: (2016)

The coming era of precision medicine for intensive care
por: Vincent, Jean-Louis
Publicado: (2017)

Nodular Thyroid Disease in the Era of Precision Medicine
por: Tumino, Dario, et al.
Publicado: (2020)

The Era of Precision Medicine: Reshaping Usher Syndrome
por: Jung, Jinsei
Publicado: (2020)

Asthma in the Precision Medicine Era: Biologics and Probiotics
por: Chiu, Chiao-Juno, et al.
Publicado: (2021)

Personalized Nursing Care in Precision-Medicine Era
por: Lopes-Júnior, Luís Carlos
Publicado: (2021)

Clinical trial design in the era of precision medicine
por: Fountzilas, Elena, et al.
Publicado: (2022)

Functional Drug Screening in the Era of Precision Medicine
por: Napoli, Giulia C., et al.
Publicado: (2022)

Emerging Therapies in CLL in the Era of Precision Medicine
por: Iyer, Prajish, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jecuhoijotcr09kt44d5pdispq